Implementation Science for Effective Risk Management of Medicines: A Call for Global Action

Area of Science:

• Pharmacovigilance
• Implementation Science
• Global Health

Background:

• Pharmaceutical risk minimization is crucial for improving drug safety but faces practical application challenges.
• Existing risk minimization standards often lack suitability for low- and middle-income countries (LMICs).
• High-income countries also struggle with consistent quality and long-term impact of risk minimization programs.

Purpose of the Study:

• To address gaps in pharmaceutical risk minimization by leveraging implementation science.
• To propose a framework for applying implementation science to enhance global medicinal product safety.
• To develop practical, sustainable recommendations for risk minimization applicable in both LMICs and high-income countries.

Main Methods:

• A call for an international expert forum to develop a pragmatic framework.
• Focus on applying implementation science best practices to pharmacovigilance.
• Development of recommendations for global risk minimization strategies.

Main Results:

• Implementation science provides robust approaches to overcome current challenges in risk minimization.
• A need for a globally applicable, practical, and sustainable framework for risk minimization.
• The proposed framework will include capacity building and dissemination plans.

Conclusions:

• Implementation science is key to advancing pharmaceutical risk minimization globally.
• A new framework and recommendations are needed for effective and equitable drug safety practices worldwide.
• The initiative aims to improve medicinal product safety through enhanced pharmacovigilance and risk management.